Effect of age on the efficacy of adjuvant chemotherapy for resected non-small cell lung cancer

Use and impact of adjuvant chemotherapy in patients with resected non-small cell lung cancer

(2014) Christina D. Williams et al.   CANCER

Cancer Incidence Among Patients of the U.S. Veterans Affairs Health Care System

(2013) Leah L. Zullig et al.   MILITARY MEDICINE

Adjuvant Chemotherapy for Non–Small-Cell Lung Cancer in the Elderly: A Population-Based Study in Ontario, Canada

(2012) Sinead Cuffe et al.   JOURNAL OF CLINICAL ONCOLOGY

Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data

(2010)   LANCET

Therapeutic options for elderly patients with advanced non-small cell lung cancer

(2009) Eric J. Avery et al.   CANCER TREATMENT REVIEWS

Randomized Phase III Trial of Vinorelbine Plus Cisplatin Compared With Observation in Completely Resected Stage IB and II Non–Small-Cell Lung Cancer: Updated Survival Analysis of JBR-10

(2009) Charles A. Butts et al.   JOURNAL OF CLINICAL ONCOLOGY

Pooled Analysis of the Effect of Age on Adjuvant Cisplatin-Based Chemotherapy for Completely Resected Non–Small-Cell Lung Cancer

(2008) Martin Früh et al.   JOURNAL OF CLINICAL ONCOLOGY

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

(2008) Jean-Pierre Pignon et al.   JOURNAL OF CLINICAL ONCOLOGY